Wed, Jul 23, 2014, 2:05 PM EDT - U.S. Markets close in 1 hr 55 mins

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • fudfighter3 fudfighter3 Dec 7, 2013 1:00 PM Flag

    Read this and weep DHW ...

    Insmed's Diabetes patent is still valid in the eleven European countries listed below. Insmed paid nine of the eleven annual renewal fees as recently as six months ago.

    Austria
    Belgium
    Finland
    France
    Germany
    Holland
    Italy
    Spain
    Sweden
    Switzerland
    United Kingdom

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The patent in question, EP1183042, covers the use of iPlex as a therapy for Diabetes. Why would Insmed still be paying renewal fees to protect the use of a drug you tell us is dead?

      "... besides it encourages the nonuthins who haven't accepted Iplex is shelved for 4 ++ years!,.... a term in biospeak that means dead ..."

      Btw - what does the term "nonuthin" mean in biospeak?

      • 1 Reply to fudfighter3
      • Thanks for that, Fud. Could you tell us where we can see the information about the renewals?

        I googled "EP1183042" and it was a fun read with some good recollections of time past. If some new people go back to read here is some help to get you to understand the import of what Fud is saying:

        ---Celtrix.....forerunner to Insmed

        ---SomatoKine......previous name of iPlex

        ---Andreas Sommer........perhaps Zake can fill this in.

        In fact, Zake, can you give some history of the information above?

        Thanks

        H

 
INSM
17.95+0.25(+1.41%)2:04 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.